Dichloromethane → HCID 67045526, compound

HRID 1034829Notes

Reaction equation

HRID 1034829 reaction equation
C(O)(C(F)(F)F)=O.[Br:8][C:9]1[C:10]([N:36]2[CH2:41][CH2:40][CH2:39][C@@H:38]([N:42](C(OC(C)(C)C)=O)[CH3:43])[CH2:37]2)=[C:11]2[C:17]([NH:18][C:19]([C:21]3[CH:26]=[CH:25][C:24](=[O:27])[N:23]([CH3:28])[CH:22]=3)=[O:20])=[CH:16][N:15](C(OC(C)(C)C)=O)[C:12]2=[N:13][CH:14]=1.C(Cl)[Cl:52]>>[ClH:52].[Br:8][C:9]1[C:10]([N:36]2[CH2:41][CH2:40][CH2:39][C@@H:38]([NH:42][CH3:43])[CH2:37]2)=[C:11]2[C:17]([NH:18][C:19]([C:21]3[CH:26]=[CH:25][C:24](=[O:27])[N:23]([CH3:28])[CH:22]=3)=[O:20])=[CH:16][NH:15][C:12]2=[N:13][CH:14]=1

Participants

4

Procedure

TFA (0.020 mL, 0.26 mmol) was added to (R)-tert-butyl 5-bromo-4-(3-(tert-butoxycarbonyl(methyl)amino)piperidin-1-yl)-3-(1-methyl-6-oxo-1,6-dihydropyridine-3-carboxamido)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate (0.034 g, 0.052 mmol) in DCM (1 mL). The reaction mixture was stirred at room temperature for 1 hour. The solvent was removed. The residue was dissolved in DCM (1 mL), and 2N HCl in ether (3 mL) was added. The solid formed was collected to give (R)—N-(5-bromo-4-(3-(methylamino)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxamide hydrochloride (25 mg, 91%) as a solid. 1H NMR (400 MHz, D2O) δ 8.34 (s, 1H), 8.30 (s, 1H), 7.97 (dd, 1H), 7.35 (s, 1H), 6.60 (d, 1H), 3.88 (m, 1H), 3.53 (s, 3H), 3.39 (m, 2H), 3.08 (m, 2H), 2.55 (s, 3H), 2.04 (m, 1H), 1.68 (m, 1H), 1.60 (m, 1H), 1.35 (m, 1H). LCMS (APCI+) m/z 459(M+H)+.

Workup

  1. customThe solvent was removed
  2. dissolutionThe residue was dissolved in DCM (1 mL)
  3. addition2N HCl in ether (3 mL) was added
  4. customThe solid formed
  5. customwas collected

Sources & evidence

ORD record
ord-46a9ceee191146bda7b6fff333670c97
Source dataset
uspto-grants-2013_10
Patent number
US08545897B2

Reaction notes

Loading…